[luidhen]

In its opinion, the EMA recommended approval of the vaccine for active immunization to prevent invasive disease, pneumonia, and acute otitis media caused by Streptococcus pneumoniae infection in infants and children between the ages of 6 weeks and 17 years. The EMA also recommended approval of the vaccine for the prevention of invasive disease caused by S pneumoniae infection in adults aged 50 years and older.

[Ссылки доступны только зарегистрированным пользователям ]